Glancy Prongay & Murray LLP Reminds Investors of Approaching Deadline in Class Action Lawsuit Against Methode Electronics, Inc. (MAY) Page 1

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming October 25, 2024 Deadline for filing a lead plaintiff motion in the class action brought on behalf of investors who purchased or otherwise acquired common stock of Methode Electronics, Inc. (“Method” or the “Company”) (NYSE: MEI) between June 23, 2022 and March 6, 2024inclusive (the “Class Period”).

If you have suffered a loss on your Method investments or would like to inquire about potential claims to recover your losses under the federal securities laws, you may submit your contact information at www.glancylaw.com/cases/Methode-Electronics-Inc/. You may also contact Charles H. Linehan of GPM at 310-201-9150, toll-free at 888-773-9224, or by email at [email protected] to learn more about your rights.

On March 9, 2023, Methode released its financial results for the third quarter of fiscal year 2023, lowering its 2023 diluted earnings per share forecast, with analysts theorizing that the miss was due to “customer production delays.” Based on this news, Methode’s stock price fell $6.21, or 13.1%, to close at $41.36 per share on March 13, 2023, hurting investors.

On June 12, 2023, Methode subsequently released its preliminary financial results for 2023, indicating that it expected to report below-range annual EPS and lower than expected net revenue guidance and diluted EPS “due to additional costs to support new program launches and the impact of program roll-offs,” among other factors. On June 22, 2023, Methode announced financial results for its fourth quarter and full fiscal year 2023, reporting net revenue that was lower than the preliminary results previously provided. On this news, Methode’s stock price fell $12.30, or 27.3%, to close at $32.77 per share on June 23, 2023.

On September 7, 2023, Methode released its financial results for the first quarter of fiscal year 2024, stating that “operational inefficiencies” in the company’s North American operations and accelerated expenses related to the launch of new programs had a negative impact on earnings for the quarter and were expected to continue into the second quarter. The company also lowered its 2024 net revenue guidance and diluted earnings per share. Based on this news, Methode’s stock price fell $6.67, or 22.2%, to close at $23.33 per share on September 7, 2023.